Massachusetts General Hospital: Hypertension trials

The registry lists 26 Hypertension studies with Massachusetts General Hospital as lead sponsor. 4 are open to participants now and 5 have results posted.

Early Phase 1 2Phase 2 4Phase 3 1Phase 4 1No phase 18(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cardiac Effects of Mineralocorticoid Receptor Antagonism After Hypertensive Disorders of PregnancyRecruitingNCT07238400Phase 2
• BRIDGE: Blood Pressure Reduction and Intervention Delivery Via Group EngagementRecruitingNCT07091851Not applicable
• Spironolactone to Improve Pregnancy-Associated Hypertension TrajectoriesRecruitingNCT07041281Phase 2
• Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic ConditionsRecruitingNCT06557005Not applicable
• Bridging the Gap From Postpartum to Primary CareCompletedNCT05543265Not applicableResults posted
• Online Trial Examining Validity and Reliability of the Shared Decision Making Process SurveyCompletedNCT04317690Results posted
• Cardiometabolic Disease and Pulmonary HypertensionTerminatedNCT03349775Early Phase 1Results posted
• Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This SettingCompletedNCT01529502Phase 2Results posted
• Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and PsoriasisTerminatedNCT00477191Not applicableResults posted
• CHW Intervention to Improve Nutrition Security of Patients With HypertensionCompletedNCT06358417Not applicable
• Blood Pressure Monitoring in Postpartum Women at Risk of HypertensionStatus unknownNCT05457504Not applicable
• Evaluating the Impact of an Equity Focused Dashboard and Clinical SupportCompletedNCT05278806Not applicable
• Virtual Cardiac Wellness Program Following Hypertensive Disorders of PregnancyActive, not recruitingNCT04998942Not applicable
• Testosterone Regulation of the Natriuretic Peptide SystemWithdrawnNCT02269072Not applicable
• Use of Inhaled Nitric Oxide to Prevent Pulmonary Hypertension Associated to Stored Blood TransfusionWithdrawnNCT02217683Phase 2
• Pulmonary Perfusion Heterogeneity in Patients With CTEPH Using Functional PET ImagingCompletedNCT02114047
• Galectin-3 Blockade in Patients With High Blood PressureCompletedNCT01960946Not applicable
• Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure: Extent of Renal DamageWithdrawnNCT01960153Phase 3
• Study of the Effect of Testosterone and Estradiol on NP Responses to Acute and Chronic Salt LoadingWithdrawnNCT01763541Early Phase 1
• Combined Use of Angiography, Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in Patients With Pulmonary Arterial Hypertension Treated With Oral BosentanWithdrawnNCT01508780Phase 4
• Evaluation of Pulmonary Perfusion Heterogeneity and Compliance in Patients With Pulmonary Hypertension Using Positron Emission Tomography ImagingCompletedNCT01461343Not applicable
• Relaxation Response Training to Treat HypertensionCompletedNCT01263743Not applicable
• DAYLIGHT: Vitamin D Therapy in Individuals at High Risk of HypertensionCompletedNCT01240512Not applicable
• The Impact of GlowCaps Connect™ and Its Services on Hypertension Medication AdherenceCompletedNCT00985452Not applicable
• Blood Pressure Self Management for Hypertension & Prehypertension Using an Internet Enabled, Automated Self Management ProgramCompletedNCT00786162Not applicable
• Improving Adherence in Patients With Hypertension - A Novel Use of Communication TechnologyCompletedNCT00277381Not applicable